Joe Eddison

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

TaILOR: a randomised trial to compare the clinical and cost-effectiveness of a patient-initiated follow-up (PIFU) strategy compared to standard care pathways in people with inflammatory arthritis: a study protocol.

TaILOR: a randomised trial to compare the clinical and cost-effectiveness of a patient-initiated follow-up (PIFU) strategy compared to standard care pathways in people with inflammatory arthritis: a study protocol.

Journal: Trials

Published: December 23, 2025

Development of patient-initiated follow-up resources for UK rheumatology departments: a co-design study with patient and clinician collaboration.

Development of patient-initiated follow-up resources for UK rheumatology departments: a co-design study with patient and clinician collaboration.

Journal: The Lancet. Rheumatology

Published: July 09, 2025

Delayed diagnosis of axial spondyloarthritis: the crucial role of primary care - how you can make a difference.

Delayed diagnosis of axial spondyloarthritis: the crucial role of primary care - how you can make a difference.

Journal: The British journal of general practice : the journal of the Royal College of General Practitioners

Published: February 27, 2025

Executive Summary: The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs.

Executive Summary: The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs.

Journal: Rheumatology (Oxford, England)

Published: January 23, 2025

What is the economic burden of delayed axial spondyloarthritis diagnosis in the UK?

What is the economic burden of delayed axial spondyloarthritis diagnosis in the UK?

Journal: Rheumatology (Oxford, England)

Published: November 21, 2024

Empowering people to take control of their persistent low back pain through public awareness campaigning.

Empowering people to take control of their persistent low back pain through public awareness campaigning.

Journal: Rheumatology (Oxford, England)

Published: October 25, 2024

The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs.

The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs.

Journal: Rheumatology (Oxford, England)

Published: August 31, 2024

Evaluation of the current use of MRI to aid the diagnosis of axial spondyloarthritis in the UK: results from a freedom of information request.

Evaluation of the current use of MRI to aid the diagnosis of axial spondyloarthritis in the UK: results from a freedom of information request.

Journal: Clinical radiology

Published: April 10, 2023

Treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope.

Treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope.

Journal: Rheumatology advances in practice

Published: February 08, 2023

Showing 1-9 of 9

Last Updated: 09/26/2026